BSEInsider Trading / SAST28 Sept 2026
Earkart Ltd
Intimation of Closure of Trading Window from the date of 1st October'' 2026 until 48 hours after the declaration of the financial results of the Company for the half year ended on 30th September 2026.
The Trading window shall re-open after the expiry of 48 hours from the declaration of aforesaid financial results.
Earkart Ltd has closed its trading window from 1st October 2026 until 48 hours after the declaration of its half-yearly financial results, which are due on 30th September 2026.
BSEGeneralExpansion24 Sept 2026
Earkart Ltd
To take the approval of Board for Incorporation of Wholly-owned Subsidiary of Earkart Limited
Earkart Ltd has announced the incorporation of a wholly-owned subsidiary, SkillNest Educations Private Limited, to expand and diversify its business operations in the education-related services sector.
BSEAGM/EGM23 Jun 2026
Earkart Ltd
The 5th Annual General Meeting (AGM) of Earkart Limited (Formerly known as Earkart Private Limited) (''''The Company'''') will be held on Wednesday, 15 July 2026, at 03:00 P.M.(IST) through ....
Earkart Ltd has announced that its 5th Annual General Meeting (AGM) for the financial year 2025-26 will be held on Wednesday, July 15, 2026, at 03:00 P.M. (IST) through Video Conferencing or Other Audio-Visual Means. The meeting will review the annual report and financial statements for the year ended March 31, 2026. The company has set July 08, 2026, as the cut-off date for determining eligible shareholders for voting, and remote e-voting facilities will be provided.
BSECompany Update▲ PositiveExpansion22 Jun 2026
Earkart Ltd
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing and Disclosure Requirements) Regulations, 2015, as amended ,(''Listing Obligations''), read with para A ....
Earkart Ltd has announced the incorporation of its new foreign subsidiary, Earkart Health Limited, in the United Kingdom on June 8, 2026. Earkart holds a 65% stake in the new entity, which has a paid-up share capital of GBP 10,000, with Earkart investing GBP 6,500. The subsidiary's objective is to provide healthcare services and sell related products, aligning with Earkart's main line of business. This strategic move signals international expansion into the UK healthcare market. Being newly formed, it currently has no turnover.